The Readout Loud

324 Episodes

1. 321: Summit's upcoming cancer results, Recursion's mixed data, and the next big obesity target

   Published: 9/5/2024
2. 320: Jim Wilson's next venture, a surprise startup shutdown, & Lilly's Zepbound strategy

   Published: 8/29/2024
3. From "Say More": What Happens When AI Decides Your Medical Coverage

   Published: 8/23/2024
4. 319: BioMarin's executive shakeup, a GLP-1 lowers diabetes risk, and a deep look at Recursion's AI bona fides

   Published: 8/22/2024
5. 318: Drug pricing drops & psychedelics under fire

   Published: 8/15/2024
6. 317: VC struggles, drug pricing negotiations, & Novo's abrupt Wegovy decision

   Published: 8/8/2024
7. 316: The long journey to make malaria vaccines, and Sarepta's ties with patient advocates

   Published: 8/1/2024
8. 315: UnitedHealth's doctor empire, an FDA departure, and Viking's obesity moves

   Published: 7/25/2024
9. 314: JD Vance's biotech ties, Cassava resignations, and insulin shortages

   Published: 7/18/2024
10. 313: Biotech layoffs, founder-focused VC, & a big pharma exit

    Published: 7/11/2024
11. 312: Medicare coverage for GLP-1 drugs, AI, and health care at the presidential debate

    Published: 6/27/2024
12. 311: Fauci's memoir, Alnylam's tenuous trial, and a mid-year review

    Published: 6/20/2024
13. 310: Duchenne gene therapy setback, Alzheimer's drug endorsement & why a STAT reporter buys weed (for journalism)

    Published: 6/13/2024
14. 309: Psychedelics at the FDA, ASCO recap, & MorphoSys update

    Published: 6/6/2024
15. 308: An ASCO preview & another Duchenne trial failure

    Published: 5/30/2024
16. 307: More tumult at BIO & coercive care for sickle cell patients

    Published: 5/23/2024
17. 306: Live! From the STAT Breakthrough Summit West

    Published: 5/16/2024
18. 305: Everything you need to know about H5N1 bird flu

    Published: 5/9/2024
19. 304: Controversial brain tissue research, obesity drug sales and Novartis’ M&A drama

    Published: 5/2/2024
20. 303: A new obesity startup, an acquisition gone wrong, & the future of Teledoc

    Published: 4/18/2024